Lysulin, Inc. San Diego, CA
Title: Glucose Toxicity: The Worldwide Problem and the All-Natural Solution
Biography:
He was the founder of Dexcom, the leader in continuous glucose monitoring for people with diabetes and he has spent most of his career developing and commercializing products that empower people with diabetes to live longer, healthier lives. They came up with their patent pending formulation and launched their first product, Lysulin, in January 2018. Lysulin is a nutritional supplement, available OTC, for people with Type 2 diabetes, prediabetes and metabolic syndrome that contains three active ingredient that have all been shown to lower blood glucose levels, as well as glycated proteins, like HbA1c. They share the belief that glycated proteins are the underlying cause of diabetes complications. Lysulin also improves the lipid profile by lowering cholesterol, LDL and triglycerides and raising HDL. Lysulin holds the promise to slow or halt the progression of diabetes disease complications. Double blind, placebo controlled clinical studies are currently underway to prove that Lysulin improves glycemic control.